Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of Jun 22
 +1.00 / +0.86%
Today’s Change
Today|||52-Week Range
FBT Regular Dividend: FBT began trading ex-dividend on 06/22/17. A $0.00 dividend will be paid to shareholders of record as of 06/26/17.

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month+9.85% 3 years+13.11%
3 months+13.35% 5 years+21.89%
1 year+31.74% Since inception+17.62%
Data through 06/23/2017

Quote Details

Previous close$116.81
Open day’s range116.82 – 119.00
Net asset value (NAV)117.80 (06/22/2017)
Daily volume106,023
Average volume (3 months)49,561
Data as of 6:29pm ET, 06/22/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+21.89%+16.30%
Expense Gross exp ratio0.56%1.33%
Risk 5 year sharpe ratio0.881.14
Net assets$930.8M$2.9B
Average market cap$9.4B$28.9B
Average P/E23.622.4
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ALNY Alnylam Pharmaceuticals Inc4.33%
REGN Regeneron Pharmaceuticals4.06%
QGEN Qiagen NV3.83%
MYGN Myriad Genetics Inc3.78%
TECH Bio-Techne Corp3.61%
NKTR Nektar Therapeutics3.54%
GRFS Grifols SA3.52%
VRTX Vertex Pharmaceuticals Inc3.47%
XON Intrexon Corp3.46%
Q Quintiles IMS Holdings Inc3.44%